Merck KGaA (OTCMKTS:MKKGY – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 12,900 shares, a growth of 1,742.9% from the October 15th total of 700 shares. Based on an average trading volume of 88,800 shares, the days-to-cover ratio is presently 0.1 days.
Merck KGaA Trading Down 0.2 %
Shares of OTCMKTS MKKGY traded down $0.07 during mid-day trading on Wednesday, hitting $32.05. The stock had a trading volume of 80,516 shares, compared to its average volume of 66,111. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. Merck KGaA has a 1 year low of $28.98 and a 1 year high of $39.17. The business has a 50 day moving average price of $34.85 and a two-hundred day moving average price of $35.15. The firm has a market cap of $20.71 billion, a P/E ratio of 22.65, a price-to-earnings-growth ratio of 2.40 and a beta of 0.96.
Wall Street Analyst Weigh In
Separately, The Goldman Sachs Group began coverage on shares of Merck KGaA in a research note on Thursday, September 19th. They set a “buy” rating on the stock.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
- Five stocks we like better than Merck KGaA
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Rocket Lab is the Right Stock for the Right Time
- Buy P&G Now, Before It Sets A New All-Time High
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Learn Technical Analysis Skills to Master the Stock Market
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.